Sign in
Taking people in United StatesNo phase

Looking for biomarkers that show which diabetic foot ulcers may heal

Studies biomarkers that may show which diabetic foot ulcers heal.

Key facts

Who runs it
University of Michigan
Where
Ann Arbor, Atlanta, Boston, Lake Success, Los Angeles, Pittsburgh, San Antonio, San Francisco, and Tucson, United StatesSee the 9 sites
Trial code
Registry title
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
Status
Recruiting
People taking part
5,000 people, planned
Started
15 Jun 2023
Expected to end
15 Jun 2028
Type of study
Observational
Record updated
9 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with diabetes who have an open foot ulcer. It tests markers that may show which ulcers will heal.

Age
18 years or older
Sex
All sexes can join
Disease stage
An open wound on the foot, from the ankle bone down. Wounds left open after surgery in this area also count.
Earlier treatment
People cannot join if they took part in a treatment trial for diabetic foot ulcer within 1 month of Visit 1.

Main reasons for not taking part

  • Now getting radiation to the ulcer area, or chemotherapy
  • Gangrene (dead tissue) anywhere in the foot with the studied ulcer
  • Planned or possible surgery to restore blood flow to that leg within 4 weeks
  • Very poor blood flow to the leg (SVS WIfI Ischemia grade 3)
  • Other medical or mental health problems that would make it unsafe to finish the study

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Provision of signed and dated informed consent form
  • Age 18 years or older
  • Clinically diagnosed with diabetes or meeting the American Diabetes Association (ADA) criteria. [ADA Standards of Clinical Care Diabetes Care 2022, Suppl 1]
  • Open foot ulcer, defined as an open wound from malleolus down. This includes post-surgical wounds within this area left open to heal by secondary intention. In case of multiple ulcers, the largest ulcer will be considered the study index DFU
  • Agreement to adhere to protocol visits and provide all required biospecimens and clinical data

Who cannot take part

  • Currently receiving radiation to target area or chemotherapy
  • Any concomitant medical or psychiatric condition that, in the opinion of the investigator(s), would compromise the participant's ability to safely complete the study
  • Gangrene in any portion of the foot with the index ulcer
  • Participation in an interventional clinical trial for DFU within 1 month of Visit 1
  • Planned revascularization or under evaluation for revascularization of the index limb for advanced ischemia within next 4 weeks of Week 0
  • Severe limb ischemia (SVS WIfl Ischemia grade 3)

Where in United States

  • University of MichiganAnn Arbor, United StatesContact: Kourtney NollTaking people
  • Emory University School of MedicineAtlanta, United StatesContact: Nazanin SoleimanmaneshTaking people
  • Beth Israel Deaconess Medical CenterBoston, United StatesContact: Aristidis VevesTaking people
  • Northwell HealthLake Success, United StatesContact: Amit RaoTaking people
  • University of Southern CaliforniaLos Angeles, United StatesNo longer taking part
  • University of PittsburghPittsburgh, United StatesContact: Shomita SteinerTaking people
  • University of Texas Health - San AntonioSan Antonio, United StatesContact: Lawrence LaveryTaking people
  • University of California San FranciscoSan Francisco, United StatesContact: Claudio GamboaTaking people
  • University Of Arizona College Of MedicineTucson, United StatesContact: Fleur MaturoTaking people

About the trial

What the trial wants to find out

This study is a platform study designed to efficiently test multiple biomarkers to identify diabetic foot ulcers (DFUs) with a higher potential for healing versus not healing that ultimately could be applied at the point of care to drive personalized management decisions, and to better inform clinical trials of wound healing interventions

The group in the trial

  • Diabetic Foot Ulcer

    Adult individuals with at least one diabetic foot ulcer who meet inclusion/exclusion criteria

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Predictive and Diagnostic Biomarkers for Diabetic Foot Ulcers: Open Wound Master Study
Plain-language title
Looking for biomarkers that show which diabetic foot ulcers may healGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
9 September 2026